Abstract
Renal cell carcinoma (RCC) is the most common cancer in the kidneys. Until 2005, treatment options were limited to immunotherapy. Since that time, there have been numerous targeted therapy agents approved with improved efficacy toward RCC. Pazopanib is a multi-tyrosine kinase inhibitor that was approved by the US Food and Drug Administration in October 2009 and by the European Medicines Agency in June 2010 for the treatment of metastatic RCC. The objective of this report was to review pazopanib's mechanism of action; pharmacologic, pharmacokinetic, and dynamic properties; potential drug interactions; and the results of clinical trials evaluating efficacy and tolerability associated with pazopanib for the treatment of RCC. MEDLINE, International Pharmaceutical Abstracts, and Web of Science were searched for English-only clinical trials and therapeutic reviews (publication dates: 2000-January 1, 2012). Abstracts from the 2000 to 2011 meetings of the American Society of Clinical Oncology were searched for an updated safety profile and tolerability data of pazopanib in RCC. References from relevant articles were reviewed. Key search terms included pazopanib, Votrient, GW786034, renal cell carcinoma, adverse events, pharmacology, ph...Continue Reading
References
Mar 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edward M MessingUNKNOWN Eastern Cooperative Oncology Group/Intergroup trial
Jun 18, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph I ClarkKim A Margolin
May 10, 2005·Diagnostic Cytopathology·Maria Sironi, Gianni Tunesi
Feb 10, 2007·Current Oncology Reports·Guru Sonpavde, Thomas E Hutson
Aug 12, 2008·Current Cancer Drug Targets·Georgios Lainakis, Aristotle Bamias
Apr 4, 2009·Cancer Chemotherapy and Pharmacology·David J Reeves, Chin Y Liu
Jun 11, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Herbert I HurwitzLini Pandite
Dec 4, 2009·Expert Opinion on Pharmacotherapy·Suwicha Limvorasak, Edwin M Posadas
Dec 17, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas E HutsonRobert A Figlin
Jan 27, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cora N SternbergRobert E Hawkins
Jan 13, 2012·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Citations
Apr 2, 2013·Angiogenesis·E M ProkopiouJ J Walsh
Aug 9, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A Ravaud, M Schmidinger
Dec 17, 2014·Expert Opinion on Drug Safety·Giuseppe BronteAntonio Russo
Sep 12, 2012·European Urology·Sergio BracardaVerena De Angelis
Dec 15, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B Pérez-ValderramaJ L González Larriba
Sep 26, 2015·Oral Oncology·Anna YuanNathaniel S Treister
Nov 1, 2014·Thoracic Cancer·Hong-Lin ZhaoQing-Hua Zhou
Apr 23, 2016·Clinical Genitourinary Cancer·Satoshi NodaTomohiro Terada
Mar 31, 2015·Cancer Treatment Reviews·Maikel HerbrinkJos H Beijnen
Aug 30, 2016·Seminars in Cell & Developmental Biology·A Marcell SzászGyörgy Marko-Varga
Nov 9, 2016·Clinical Sarcoma Research·Astrid LipplaaHans Gelderblom
Jan 6, 2017·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Li-Tzong ChenYoon-Koo Kang
Apr 12, 2017·Antioxidants & Redox Signaling·Carlo Gabriele TocchettiGiuseppe Mercuro
Jan 26, 2017·Chemical Biology & Drug Design·Beata ŻołnowskaTomasz Bączek
Feb 3, 2016·Therapeutic Advances in Urology·David Cella, Jennifer L Beaumont
May 19, 2018·International Journal of Molecular Sciences·Beata ŻołnowskaJarosław Chojnacki
Nov 30, 2019·British Journal of Clinical Pharmacology·Kim WesterdijkUNKNOWN Dutch Pharmacology and Oncology Group (DPOG)
Feb 9, 2017·Oncotarget·Chiara MassaBarbara Seliger
Sep 13, 2014·Oncotarget·Rogerio B CraveiroDagmar Dilloo
Jul 2, 2018·Archives of Pharmacal Research·Hyojeong Choi, Aree Moon
Dec 11, 2019·Cancers·Magesh MuthuAnders Nordström
Jul 12, 2018·BioMed Research International·Claudia ArenaLorenzo Lo Muzio
Nov 28, 2018·BMC Pharmacology & Toxicology·María José Méndez-VidalEnrique Gallardo
Jul 6, 2017·Pharmacogenetics and Genomics·Caroline F ThornTeri E Klein
Feb 27, 2021·Chemical Communications : Chem Comm·Xiong ChenJinlan Zhang
Apr 21, 2018·Bioorganic Chemistry·Wuji SunHong Yan
Nov 27, 2020·Experimental Animals·Baran AkagunduzHalis Suleyman
Aug 28, 2021·European Journal of Medicinal Chemistry·Osama M SoltanMohamed Abdel-Aziz